Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosisNitin J. Karandikar, Michael K. Racke, Michael P. Crawford et al.|Journal of Clinical Investigation|2002Cited by 177
Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosisNitin J. Karandikar, Michael K. Racke, Xiao‐Jie Yan et al.|Journal of Clinical Investigation|2002Cited by 175
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLLAndreas Agathangelidis, Arnon P. Kater, Anastasia Chatzidimitriou et al.|Blood|2020Cited by 132
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A. Burger, Nicholas Chiorazzi, Kelvin W. Li et al.|JCI Insight|2017Cited by 93
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemiaJane Houldsworth, R. S. K. Chaganti, Asha Guttapalli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 33